Literature DB >> 15770726

Hepatocyte growth factor gene therapy prevents radiation-induced liver damage.

Chau-Hua Chi1, I-Li Liu, Wei-Yu Lo, Bor-Song Liaw, Yu-Shan Wang, Kwan-Hwa Chi.   

Abstract

AIM: To transfer human HGF gene into the liver of rats by direct electroporation as a means to prevent radiation-induced liver damage.
METHODS: Rat whole liver irradiation model was accomplished by intra-operative approach. HGF plasmid was injected into liver and transferred by electroporation using a pulse generator. Control rats (n = 8) received electrogene therapy (EGT) vehicle plasmid and another 8 rats received HGF-EGT 100 mug 48 h before WLIR. Expression of HGF in liver was examined by RT-PCR and ELISA methods. Apoptosis was determined by TUNEL assay. Histopathology was evaluated 10 wk after whole liver irradiation.
RESULTS: Marked decrease of apoptotic cells and down-regulation of transforming growth factor-beta 1 (TGF-beta1) mRNA were observed in the HGF-EGT group 2 d after liver irradiation compared to control animals. Less evidence of radiation-induced liver damage was observed morphologically in liver specimen 10 wk after liver irradiation and longer median survival time was observed from HGF-EGT group (14 wk) compared to control rats (5 wk). (P = 0.031).
CONCLUSION: For the first time it has been demonstrated that HGF-EGT would prevent liver from radiation-induced liver damage by preventing apoptosis and down-regulation of TGF-beta1.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15770726      PMCID: PMC4305692          DOI: 10.3748/wjg.v11.i10.1496

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  35 in total

Review 1.  Partial irradiation of the liver.

Authors:  L A Dawson; R K Ten Haken; T S Lawrence
Journal:  Semin Radiat Oncol       Date:  2001-07       Impact factor: 5.934

2.  Intramuscular injection of an adenoviral vector expressing hepatocyte growth factor facilitates hepatic transduction with a retroviral vector in mice.

Authors:  C Gao; R Jokerst; P Gondipalli; S R Cai; S Kennedy; K P Ponder
Journal:  Hum Gene Ther       Date:  1999-04-10       Impact factor: 5.695

3.  Anti-tumor effect of in vivo IL-2 and GM-CSF electrogene therapy in murine hepatoma model.

Authors:  Chau-Hwa Chi; Yu-Shan Wang; Yen-Shuae Lai; Kwan-Hwa Chi
Journal:  Anticancer Res       Date:  2003 Jan-Feb       Impact factor: 2.480

4.  The chronological development of late radiation injury in the liver of the rat.

Authors:  D W Hebard; K L Jackson; G M Christensen
Journal:  Radiat Res       Date:  1980-03       Impact factor: 2.841

5.  Modulation of transforming growth factor beta function in hepatocytes and hepatic stellate cells in rat liver injury.

Authors:  M Date; K Matsuzaki; M Matsushita; Y Tahashi; F Furukawa; K Inoue
Journal:  Gut       Date:  2000-05       Impact factor: 23.059

6.  Antisense thymidylate synthase electrogene transfer to increase uptake of radiolabeled iododeoxyuridine in a murine model.

Authors:  Kwan-Hwa Chi; Hsin-Ell Wang; Yu-Shan Wang; Shun-Lan Chou; Hung-Man Yu; Yu-Hua Tseng; Ing-Ming Hwang; Wing-Yiu Lui
Journal:  J Nucl Med       Date:  2004-03       Impact factor: 10.057

Review 7.  Transforming growth factor-beta (TGF-beta): a key-role in liver fibrogenesis.

Authors:  P Bedossa; V Paradis
Journal:  J Hepatol       Date:  1995       Impact factor: 25.083

8.  Radiation hepatology of the rat: parenchymal and nonparenchymal cell injury.

Authors:  J P Geraci; M S Mariano
Journal:  Radiat Res       Date:  1993-11       Impact factor: 2.841

9.  Scatter factor protects epithelial and carcinoma cells against apoptosis induced by DNA-damaging agents.

Authors:  S Fan; J A Wang; R Q Yuan; S Rockwell; J Andres; A Zlatapolskiy; I D Goldberg; E M Rosen
Journal:  Oncogene       Date:  1998-07-16       Impact factor: 9.867

Review 10.  The many faces of hepatocyte growth factor: from hepatopoiesis to hematopoiesis.

Authors:  R Zarnegar; G K Michalopoulos
Journal:  J Cell Biol       Date:  1995-06       Impact factor: 10.539

View more
  7 in total

1.  The clinical value of serum hepatocyte growth factor levels in patients undergoing primary radiotherapy for glioma: effect on progression-free survival.

Authors:  Qing-le Liang; Zheng-ying Mo; Ping Wang; Xiao Li; Zhi-xiang Liu; Zhang-ming Zhou
Journal:  Med Oncol       Date:  2014-07-27       Impact factor: 3.064

2.  Radiation damage and radioprotectants: new concepts in the era of molecular medicine.

Authors:  M I Koukourakis
Journal:  Br J Radiol       Date:  2012-01-31       Impact factor: 3.039

Review 3.  Hepatocyte growth factor in lung repair and pulmonary fibrosis.

Authors:  Ronald Allan M Panganiban; Regina M Day
Journal:  Acta Pharmacol Sin       Date:  2010-12-06       Impact factor: 6.150

4.  Human CD34+ cells mobilized by granulocyte colony-stimulating factor ameliorate radiation-induced liver damage in mice.

Authors:  Ning Li; Li Zhang; Huixiang Li; Baijun Fang
Journal:  Stem Cell Res Ther       Date:  2010-07-15       Impact factor: 6.832

5.  Long-term pathological and immunohistochemical features in the liver after intraoperative whole-liver irradiation in rats.

Authors:  Masumi Imaeda; Hitoshi Ishikawa; Yukari Yoshida; Takeo Takahashi; Yu Ohkubo; Atsushi Musha; Mayumi Komachi; Yoichi Nakazato; Takashi Nakano
Journal:  J Radiat Res       Date:  2014-02-23       Impact factor: 2.724

6.  Hepatocyte growth factor gene-modified adipose-derived mesenchymal stem cells ameliorate radiation induced liver damage in a rat model.

Authors:  Jiamin Zhang; Shiyuan Zhou; Yi Zhou; Feier Feng; Qianming Wang; Xiaolu Zhu; Huisheng Ai; Xiaojun Huang; Xiaohui Zhang
Journal:  PLoS One       Date:  2014-12-12       Impact factor: 3.240

7.  Glibenclamide, a diabetic drug, prevents acute radiation induced liver injury of mice via up-regulating intracellular ROS and subsequently activating Akt-NF-κB pathway.

Authors:  Hu Liu; Shichao Wang; Zhao Wu; Ziyun Huang; Wei You Chen; Yanyong Yang; Jianguo Cui; Cong Liu; Hainan Zhao; Jiaming Guo; Pei Zhang; Fu Gao; Bailong Li; Jianming Cai
Journal:  Oncotarget       Date:  2017-06-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.